NPWR Investors Have Opportunity to Lead NET Power Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NET Power Inc. ('Net Power' or 'the Company') (NYSE: NPWR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between June 9, 2023 and March 7, 2025, inclusive (the 'Class Period'), are encouraged to contact the firm before June 17, 2025.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Net Power was unlikely to complete Project Permian on time and on budget due to supply chain issues and multiple issues specific to the site and region. The Company's projections about the time and financial resources required to complete Project Permian were not based in reality. The Company's financial results and business would be negatively impacted by the delays and cost overruns associated with Project Permian. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Net Power, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Microsoft Shares Slip as OpenAI Dispute Sparks Antitrust Concerns
June 17 - Microsoft (NASDAQ:MSFT) shares edged down 0.7% in Tuesday morning trading as tensions with OpenAI intensified, with disagreements over their partnership structure threatening to derail future collaboration. OpenAI executives have reportedly discussed accusing Microsoft of anticompetitive behavior and possibly involving federal regulators. At the center of the conflict are disputes over Microsoft's future stake in OpenAI, and access to intellectual property from OpenAI's recent acquisition of Windsurf, a coding startup. Warning! GuruFocus has detected 6 Warning Sign with MSFT. Microsoft has invested $13 billion in OpenAI since 2019, gaining a share of future profits rather than equity. However, the partnership is now under pressure amid OpenAI's pivot toward becoming a public-benefit corporation, after backing off plans to convert into a traditional for-profit company. The restructuring is a key condition for a $30 billion investment from Japan's SoftBank, which values OpenAI at $300 billion. That funding would support OpenAI's continued use of Microsoft's cloud infrastructure, although OpenAI has also signed deals with other providers including Oracle (NYSE:ORCL) and CoreWeave. Despite the friction, both companies said in a joint statement that talks are ongoing and they remain optimistic about their partnership's future. This article first appeared on GuruFocus.
Business Upturn
32 minutes ago
- Business Upturn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Verve Therapeutics, Inc. (NASDAQ: VERV)'s sale to Eli Lilly and Company. Under the terms of the proposed transaction, Verve shareholders will receive $10.50 per share in cash, plus one non-tradeable contingent value right per share entitling the holder to receive up to an additional $3.00 per share upon the achievement of certain milestones. If you are a Verve shareholder, click here to learn more about your rights and options. Sage Therapeutics, Inc. (NASDAQ: SAGE)'s sale to Supernus Pharmaceuticals, Inc. Under the terms of the proposed transaction, Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable upon achieving certain net sales and commercial milestones. If you are a Sage shareholder, click here to learn more about your legal rights and options. Cantaloupe, Inc. (NASDAQ: CTLP)'s sale to 365 Retail Markets, LLC for $11.20 per share in cash. If you are a Cantaloupe shareholder, click here to learn more about your rights and options. Volato Group, Inc. (NYSE: SOAR)'s merger with M2i Global, Inc. Upon completion of the proposed transaction, current Volato shareholders will own approximately 10% of the combined company. If you are a Volato shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Halper, World Trade Center85th FloorNew York, NY 10007(212) 763-0060 [email protected] [email protected]
Business Upturn
33 minutes ago
- Business Upturn
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ
PHILADELPHIA, June 17, 2025 (GLOBE NEWSWIRE) — Maison Solutions Inc. (NASDAQ: MSS) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class action has survived a motion to dismiss the complaint. If you are a current Maison Solutions Inc. (NASDAQ: MSS) shareholder who purchased Maison shares on or near its October 5, 2023 IPO, you can seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit contact Joshua Grabar at [email protected] or call us at 267-507-6085 WHY? An underlying securities fraud class action complaint alleges that in Maison Solutions Inc.'s (NASDAQ: MSS) IPO Registration Statement and throughout the Class Period (October 5, 2023 through December 15, 2023), Maison, through certain of its officers, made materially false and/or misleading statements, including failing to disclose to investors: (1) that the Company's vendor XHJC Holdings Inc., is a related party; (2) that the Company's CEO and related entities were alleged to have used supermarkets as a front to defraud the EB-5 visa program; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On March 31, 2025, material portions of the underlying securities fraud complaint survived a motion to dismiss. WHAT YOU CAN DO NOW: If you purchased Maison Solutions Inc. (NASDAQ: MSS) shares on or near its October 5, 2023 IPO and still hold shares today, you are encouraged to visit contact Joshua Grabar at [email protected] , or call 267-507-6085. You may be able to seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $MSS #MaisonSolutions Methode Electronics, Inc. (NYSE: MEI): Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award – all at no cost to them whatsoever. To learn more visit: contact Joshua Grabar at [email protected], or call 267-507-6085. Why: A recently filed underlying securities fraud class action complaint alleges that Methode Electronics, via certain of its officers and directors, made false and/or misleading statements and/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics' transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics' attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle ('EV') space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics' strategic plans; (iii) Methode Electronics' manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis. What You Can Do Now: Current Methode Electronics shareholders who have held Methode Electronics stock since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact Joshua Grabar at [email protected], or call 267-507-6085. #Methode #MethodeElectronics $MEI Treace Medical Concepts, Inc. (NASDAQ: TMCI) If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to May 8, 2023, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit or contact Joshua H. Grabar at [email protected] or call 267-507-6085 to learn more. Why? A recently filed securities class action complaint alleges that, Treace Medical Concepts, Inc. (NASDAQ: TMCI), via certain of its officers, made materially false and/or misleading statements and failed to disclose adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical's revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. What You Can Do Now: Current Treace shareholders who have held Treace shares since prior to May 8, 2023, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact us at [email protected], or call 267-507-6085. #Treace $TMCI Xponential Fitness Inc. (NYSE: XPOF): Current Xponential Fitness Inc. (NYSE: XPOF) shareholders who have continuously held Xponential shares since on or shortly after the company's July 2021 IPO, can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award at no cost to them whatsoever. Learn more or join by Clicking email Joshua Grabar at [email protected], or call us at 267-507-6085. WHAT IS HAPPENING: Grabar Law Office is investigating claims on behalf of long-term Xponential shareholders. The investigation concerns whether certain officers of the company have breached their fiduciary duties owed to the company. BASIS OF THE INVESTIGATION: A securities fraud class action lawsuit has been filed that alleges that Xponential Fitness (NYSE: XPOF), through certain of its officers and directors, made false and misleading statements or failed to disclose that: (1) Xponential had permanently closed at least 30 stores; (2) Xponential's reported same-store sales and average unit volume metrics had been misstated by excluding underperforming stores; (3) 8 out of 10 Xponential brands were losing money monthly; (4) over 50% of Xponential studios did not make a positive financial return; (5) over 60% of Xponential's revenue was one-time and non-recurring; (6) more than 100 of Xponential's franchises were for sale at a price that is at least 75% less than their initial cost; (7) Xponential had misled many of its franchisees into opening franchises by misrepresenting the financial profile and profitability of its studios, as well as the expected rate of return for new studio openings; (8) many Xponential franchisees were substantially in debt, suffering high attrition rates and running non-viable studios that had no realistic path to profitability; and (9) based on the foregoing, defendants lacked a reasonable factual basis for their positive statements about Xponential's then-current business operations and future financial prospects. YOUR RIGHTS: Current Xponential Fitness shareholders who have held Xponential Fitness shares since on or shortly after the company's July 2021 IPO can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter or join it, you are encouraged to visit contact Joshua H. Grabar at [email protected], or call 267-507-6085. $XPOF #XponentialFitness Attorney Advertising Disclaimer Contact:Joshua H. Grabar, Law OfficeOne Liberty Place1650 Market Street, Suite 3600Philadelphia, PA 19103Tel: 267-507-6085 Email: [email protected]
